Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.69
Delayed Data
As of Apr 24
 -0.28 / -9.43%
Today’s Change
1.85
Today|||52-Week Range
4.97
+1.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization168.0K169.0K167.0K169.0K
 
 
 
 
 
 
Operating ExpensesGross Income-168.0K-169.0K-167.0K-169.0K
 
 
 
 
 
General Expenses22.7M21.5M19.3M19.7M
 
 
 
 
 
Research And Development17.6M18.8M16.2M15.7M
 
 
 
 
 
Total Operating Expenses22.9M21.7M19.4M19.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.9M-21.7M-19.4M-19.9M
 
 
 
 
 
Interest Expense On Debt650.0K585.0K517.0K458.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.6M-22.3M-20.0M-20.4M
 
 
 
 
 
Net Income-23.6M-22.3M-20.0M-20.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.4M94.0M105.8M108.4M
 
 
 
 
 
Shares To Calculate EPS Diluted85.4M94.0M105.8M108.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.24-$0.19-$0.19
 
 
 
 
 
EPS Diluted-$0.28-$0.24-$0.19-$0.19
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account